We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Georgia Healthcare Group Plc]

22 Apr 2020 13:47

RNS Number : 5340K
T.Rowe Price Associates
22 April 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

T. ROWE PRICE ASSOCIATES, INC. & ITS AFFILIATES

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GEORGIA HEALTHCARE GROUP PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

21 April 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

GEORGIA CAPITAL PLC

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,056,573

3.84

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

5,056,573

3.84

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Common Stock

Sale

 

10

0.900 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

22 April 2020

Contact name:

Gary Greb

Telephone number*:

410-345-2527

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETEAALAALLEEFA
Date   Source Headline
14th Aug 20197:00 amRNSHalf-year Report
8th Aug 201912:20 pmRNSNotice of Results
1st Aug 20194:41 pmRNSSecond Price Monitoring Extn
1st Aug 20194:35 pmRNSPrice Monitoring Extension
30th Jul 20194:41 pmRNSSecond Price Monitoring Extn
30th Jul 20194:35 pmRNSPrice Monitoring Extension
12th Jul 20197:00 amRNSGHG signs a cooperation agreement
28th Jun 20197:00 amRNSDividend Currency Conversion Rate
26th Jun 20197:00 amRNSGHG hosts Investor Day in Tbilisi
17th Jun 20193:51 pmRNSDirector/PDMR Shareholding
4th Jun 20197:00 amRNSDirector/PDMR Shareholding
3rd Jun 20193:16 pmRNSSale of land to m2 Real Estate
30th May 20193:53 pmRNSDirector/PDMR Shareholding
22nd May 20195:33 pmRNSDirector/PDMR Shareholding
22nd May 20194:12 pmRNSDirector/PDMR Shareholding
22nd May 20191:51 pmRNSResult of AGM
15th May 20197:00 amRNS1st Quarter Results
10th May 201911:30 amRNSNotice of Results
1st May 201912:07 pmRNSSecond Price Monitoring Extn
1st May 201912:02 pmRNSPrice Monitoring Extension
10th Apr 201910:54 amRNSNotice of AGM
8th Apr 20191:07 pmRNSGHG Investor Day Notice
3rd Apr 20197:00 amRNSAnnual Financial Report
2nd Apr 20199:56 amRNSDirector/PDMR Shareholding
27th Mar 20192:28 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSDividend Declaration
25th Mar 201910:03 amRNSGHG signs a partnership agreement with the ALIMP
13th Mar 20194:36 pmRNSPrice Monitoring Extension
4th Mar 20194:40 pmRNSSecond Price Monitoring Extn
4th Mar 20194:35 pmRNSPrice Monitoring Extension
27th Feb 201912:07 pmRNSSecond Price Monitoring Extn
27th Feb 201912:02 pmRNSPrice Monitoring Extension
25th Feb 20193:27 pmRNSDirector/PDMR Shareholding
22nd Feb 20197:00 amRNSGHG will hold Investor Day on 26 June
15th Feb 20197:02 amRNSFinal Results
12th Feb 20197:00 amRNSNotice of Results
28th Dec 20187:00 amRNSGHG enters the Georgian dental services market
27th Dec 20187:00 amRNSAcquisition of two medical insurance clients
24th Dec 201812:35 pmRNSPrice Monitoring Extension
17th Dec 20187:00 amRNSGHG announces the opening of Mega Laboratory
20th Nov 20187:01 amRNSIFC publishes a case study on GHG
19th Nov 20184:41 pmRNSSecond Price Monitoring Extn
19th Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 201811:30 amRNSResults of External Audit Tender Process
12th Nov 20187:00 amRNS3rd Quarter Results
8th Nov 20187:00 amRNSNotice of Results
28th Sep 20185:24 pmRNSDirector/PDMR Shareholding
21st Sep 20187:00 amRNSDirectorate Change
13th Sep 20187:10 amRNSGeorgia Day in London on 12 October
5th Sep 20184:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.